Current price is more than the intrinsic value

Intrinsic Value

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Tatva Chintan Pharma Chemicals made a strong debut on bourses today, with its share listing 95% higher to the issue price.

Tatva Chintan Pharma shares tank over 10% as Q4 profit declines 17%

ICICI Securities is bullish on Tatva Chintan Pharma Chem has recommended buy rating on the stock with a target price of Rs 2875 in its research report dated April 26, 2022.

Buy Tatva Chintan Pharma Chem: target of Rs 2875: ICICI Securities

At 10:28 IST, the barometer index, S&P BSE Sensex rallied 643.1 points or 1.14% at 57,223.13. The Nifty 50 index added 203.65 points or 1.2% at 17,157.

Nifty above 17,150; Tatva Chintan down 7%

Tatva Chintan Pharma Chem fell 7.82% to Rs 2303 after the company’s consolidated net profit declined 17.09% to Rs 17.51 crore on 9.33% decline in net sales to Rs 98.53 crore in Q4 March 2022 over Q4 March 2021.

Tatva Chintan Pharma drops after Q4 PAT slides 17% YoY

Tatva Chintan Standalone March 2022 Net Sales at Rs 101.88 crore, down 2.5% Y-o-Y

Tatva Chintan Consolidated March 2022 Net Sales at Rs 98.53 crore, down 9.33% Y-o-Y

Tatva Chintan Pharma Chem consolidated net profit declines 17.09% in the March 2022 quarter

The brokerage says it expects the chemicals company to continue to deliver strong earnings growth in line with the execution in the past

Tatva Chintan gains as Investec starts coverage with ‘buy’ call

ICICI Securities is bullish on Tatva Chintan Pharma Chem recommended buy rating on the stock with a target price of Rs 3000 in its research report dated April 06, 2022.

Buy Tatva Chintan Pharma Chem: target of Rs 3000: ICICI Securities

Clean Science, Tatva Chintan Pharma, Neogen Chemicals - Innovation Edge: Nirmal Bang Initiates Coverage

Tatva Chintan Pharma Chem is engaged in the manufacturing business  of chemical products.

Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Tatva Chintan Pharma shares tank over 10% as Q4 profit declines 17%

Buy Tatva Chintan Pharma Chem: target of Rs 2875: ICICI Securities

Nifty above 17,150; Tatva Chintan down 7%

Tatva Chintan Pharma drops after Q4 PAT slides 17% YoY

Tatva Chintan Standalone March 2022 Net Sales at Rs 101.88 crore, down 2.5% Y-o-Y

Tatva Chintan Standalone March 2022 Net Sales at Rs 101.88 crore, down 2.5% Y-o-Y

Tatva Chintan Consolidated March 2022 Net Sales at Rs 98.53 crore, down 9.33% Y-o-Y

Tatva Chintan Pharma Chem Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Tatva Chintan Pharma shares tank over 10% as Q4 profit declines 17%

Buy Tatva Chintan Pharma Chem: target of Rs 2875: ICICI Securities

Nifty above 17,150; Tatva Chintan down 7%

Tatva Chintan Pharma drops after Q4 PAT slides 17% YoY

Tatva Chintan Standalone March 2022 Net Sales at Rs 101.88 crore, down 2.5% Y-o-Y

Tatva Chintan Standalone March 2022 Net Sales at Rs 101.88 crore, down 2.5% Y-o-Y

Tatva Chintan Consolidated March 2022 Net Sales at Rs 98.53 crore, down 9.33% Y-o-Y

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock